Huons Co., Ltd. (KOSDAQ: 243070)

Market Cap	337.67B
Revenue (ttm)	580.13B
Net Income (ttm)	40.15B
Shares Out	11.85M
EPS (ttm)	3,299.10
PE Ratio	8.64
Forward PE	6.24
Dividend	660.00 (2.33%)
Ex-Dividend Date	Jun 27, 2024

Volume	48,115
Open	28,250
Previous Close	28,350
Day's Range	28,150 - 29,350
52-Week Range	26,950 - 47,250
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2023, Huons's revenue was 552.01 billion, an increase of 12.11% compared to the previous year's 492.39 billion. Earnings were 50.47 billion, an increase of 124.88%.